Oncology & Cancer

Scientists get closer to a better PSA test

The most common screening test for prostate cancer so often returns a false positive result that it's no longer recommended for men older than 70, and it's offered as a personal choice for younger men.

Oncology & Cancer

New immunotherapy holds promise for ovarian cancer

CAR T-cell therapy, a certain kind of cancer treatment in which the immune system's T cells are programmed to attack tumor cells, is effective in mice with ovarian cancer, according to a study published in The Journal for ...

Diseases, Conditions, Syndromes

Before test results, signs of COVID-19 are in water systems

Before a community hospital is stretched thin with COVID-19-patients, even before antigen tests—no matter how rapid—return results, there is one place that may be able to capture the number of COVID-19 infections in a ...

page 2 from 13